Publication | Closed Access
[Safety and efficacy of human umbilical cord derived-mesenchymal stem cell transplantation for treating patients with HBV-related decompensated cirrhosis].
17
Citations
0
References
2016
Year
Addition of the UC-MSC treatment to the standard therapy could help to improve liver function in patients with HBV-DLC.